These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6056920)

  • 1. Long-term effect of anticoagulants in obliterative arterial disease of the legs.
    Tillgren C; Lund F
    Scand J Clin Lab Invest Suppl; 1967; 99():184-6. PubMed ID: 6056920
    [No Abstract]   [Full Text] [Related]  

  • 2. [Internal conservative treatment of obliterative arteriopathies of the lower limbs].
    Toth L
    Med Pregl; 1975; 28(3-4):181-3. PubMed ID: 1177851
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the therapy of peripheral organo-angiopathies using Progresin].
    Horn HJ
    Med Klin; 1968 Aug; 63(35):1377-8 passim. PubMed ID: 5682033
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of Sadamin on some blood clotting parameters and fibrinolysis in patients with obliterative arteriosclerosis of lower limb arteries].
    Kiersnowska B; Bielawiec M; Lukjan H; Korfel B; Rogowski F; Dowzyk W
    Pol Tyg Lek; 1973 Mar; 28(11):400-3. PubMed ID: 4694796
    [No Abstract]   [Full Text] [Related]  

  • 5. Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid.
    Ost CR; Sténson S
    Scand J Clin Lab Invest Suppl; 1967; 99():241-5. PubMed ID: 6056927
    [No Abstract]   [Full Text] [Related]  

  • 6. Obliterative arterial disease of the lower limbs. IV. Evaluation of long-term anticoagulant therapy.
    Tillgren C
    Acta Med Scand; 1965 Aug; 178(2):203-19. PubMed ID: 4158084
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined fibrinolytic-clearing treatment in obliterative endareteritis in the aged patient].
    Baldoni E
    G Gerontol; 1967 Dec; 15(12):1477-89. PubMed ID: 5618944
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of patients with obliterative diseases of arteries of the lower extremities by intra-arterial administration of the drugs].
    Bogoev DN; Voskanian EA
    Khirurgiia (Mosk); 1979 Jan; (1):64-7. PubMed ID: 759703
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medical treatment of acute arterial obliteration in the limbs].
    Serradimigni A; Bory M; Poggi L; Audier M
    Rev Atheroscler (Paris); 1968; 10(2):3-8. PubMed ID: 5759950
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems in the use of anticoagulants in severe arterial occlusive diseases of the limbs].
    Linke H
    Z Gesamte Inn Med; 1970 Aug; 25(15):688-93. PubMed ID: 5527533
    [No Abstract]   [Full Text] [Related]  

  • 11. [Testosterone treatment of obliterative arterial lesions in the legs].
    Hvidt V; Dohn K; Lund J; Nielsen J; Palm L
    Ugeskr Laeger; 1965 Sep; 127(36):1116-23. PubMed ID: 5869540
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of obliterating arteriosis].
    Skripnichenko DF
    Klin Khir (1962); 1969 Apr; 4():26-31. PubMed ID: 5372189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with the treatment of peripheral vascular diseases with Xavin].
    Brücknerová O
    Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
    Scaffidi V
    Minerva Med; 1975 Jan; 66(2):55-65. PubMed ID: 1113917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
    Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of myocalm on the hemodynamics of peripheral and kidney circulation in subjects with healthy blood vessels and in patients with obliterative arterial vascular diseases].
    Hackel F
    Z Gesamte Inn Med; 1966 Jul; 21(14):435-9. PubMed ID: 5992292
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of excitation of femoral artery baroreceptors by arterial pumping on the arterial flow in the legs of patients with arteriosclerosis obliterans of the lower limbs].
    Uza G; Iancu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(4):321-5. PubMed ID: 43567
    [No Abstract]   [Full Text] [Related]  

  • 18. The significance of vasodilator therapy in obliterative arterial disease.
    Thulesius O
    Scand J Clin Lab Invest Suppl; 1967; 99():222-4. PubMed ID: 6056925
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antithrombotic prophylaxis of the complications of arteriosclerosis obliterans].
    Heine H; Norden K; Heinemann L; Stepanauskas M; Schmidt H
    Kardiologiia; 1981 Aug; 21(8):76-80. PubMed ID: 7289389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and hemodynamic effects of captopril in patients with arterial hypertension and obliterative arteriopathy of the legs].
    Bolognini G; Iezzi Biase G
    Clin Ter; 1986 Feb; 116(4):287-9. PubMed ID: 3516544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.